ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

What Is the Optimal Model to Estimate the Benefits of Chemotherapy in Patients With Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer?

Kenju Ando et al.PubMed ↗Publisher ↗

No numbers read from the abstract.